Loading...
Current Chemotherapy and Potential New Targets in Uterine Leiomyosarcoma
A variety of chemotherapeutic agents have been used for treating recurrent or advanced stage uterine leiomyosarcoma (ULMS). The response rates of these current agents are disappointing, with partial response rates varying from 0% to 33%, and complete response rates varying from 0% to 8%. Recent stud...
Na minha lista:
| Udgivet i: | J Clin Med Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elmer Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4737027/ https://ncbi.nlm.nih.gov/pubmed/26858789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2419w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|